Will this small molecule drug replicate from mouse testing to humans?

A therapeutic small molecule enhances γ-oscillations and improves cognition/memory in Alzheimer’s disease model mice | PNAS

Definitely resolves 'yes' if it ends up FDA approved, but much more modest (e.g. pre-clinical) studies may also be reason to resolve either way.

Not trading myself, because not being a biologist it will be already hard enough to navigate.